Characterization of Exosomes Platelets-released

Launched by CENTRO CARDIOLOGICO MONZINO · Mar 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying tiny particles called exosomes that are released by platelets, which are a type of blood cell. These exosomes play an important role in how cells communicate with each other and may help us understand certain heart diseases better. Researchers want to learn more about how these exosomes behave, especially in relation to treatments that prevent blood clots. By gathering this information, they hope to find new ways to diagnose and treat cardiovascular issues.

To participate in this trial, individuals need to be between the ages of 20 and 65 and should not have any known health problems. This means that people with conditions like cancer, heart disease, or any major organ issues are not eligible. If you decide to join the trial, you can expect to provide blood samples, which will help researchers study the exosomes. Participating in this trial could contribute to important medical discoveries that benefit others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • subjects without known pathologies
• Exclusion Criteria:
• • individuals with gastrointestinal diseases,
• • individuals with history of hepatic diseases,
• • individuals with history of urogenital diseases,
• • individuals with history of hematological diseases,
• • individuals with history of immunological diseases,
• • individuals with history of renal diseases,
• • individuals with history of metabolic diseases
• • individuals with history of respiratory diseases
• • individuals with history of cancer
• • individuals with history of cardiovascular disease
• • individuals having permanent organ damage
• • individuals with major trauma in the last 6 months prior to enrollment
• • individuals with surgery in the last 6 months prior to enrollment
• • individuals taking medication in the 15 days prior to enrolment.